当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Acetaminophen, Phenylephrine, Dextromethorphan Hydrobromide, Doxylamin
DRUG FOR FURTHER PROCESSING
0280-1201
Bayer HealthCare LLC.
2017/1/7 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
0280-1201_
Dextromethorphan hydrobromide, paracetamol, phenylephrine hydrochlorid
DRUG FOR FURTHER PROCESSING
0280-1203
Bayer HealthCare LLC.
2017/7/1 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
0280-1203_
Alka Seltzer Plus Free Cold and Flu Day Liqui-Gels
DRUG FOR FURTHER PROCESSING
0280-1205
Bayer HealthCare LLC.
2016/7/1 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
0280-1205_
Dextromethorphan hydrobromide, Chlorpheniramine maleate, Acetaminophen
DRUG FOR FURTHER PROCESSING
0280-1206
Bayer HealthCare LLC.
2017/1/15 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
0280-1206_
ASP Free Cold and Flu Ni.LF. BLM
DRUG FOR FURTHER PROCESSING
0280-1210
Bayer HealthCare LLC.
2016/7/1 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
0280-1210_
ASP SS CA C LG BLM
DRUG FOR FURTHER PROCESSING
0280-1220
Bayer HealthCare LLC.
2015/3/6 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
0280-1220_
Dextrmethorphan hydrobromide monohydrate, Paracetamol, Phenylephrine h
DRUG FOR FURTHER PROCESSING
0280-1235
Bayer HealthCare LLC.
2017/1/1 0:00:00
ACETAMINOP
DRUG FOR FURTHER PROCESSING
0280-1235_
Aspirin, Dextromethorphan hydrobromide, and Phenylephrine bitartrate
HUMAN OTC DRUG
0280-1410
Bayer HealthCare LLC.
2010/8/1 0:00:00
ASPIRIN; D
DRUG FOR FURTHER PROCESSING
0280-1410_
Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromet
HUMAN OTC DRUG
0280-1430
Bayer HealthCare LLC.
2010/8/1 0:00:00
ASPIRIN; D
DRUG FOR FURTHER PROCESSING
0280-1430_
Anastrozole
DRUG FOR FURTHER PROCESSING
0310-0201
AstraZeneca Pharmaceuticals LP
2019/4/3 0:00:00
ANASTROZOL
DRUG FOR FURTHER PROCESSING
1
0310-0201_
quetiapine
DRUG FOR FURTHER PROCESSING
0310-0505
AstraZeneca Pharmaceuticals LP
2022/4/22 0:00:00
QUETIAPINE
DRUG FOR FURTHER PROCESSING
50
0310-0505_
quetiapine
DRUG FOR FURTHER PROCESSING
0310-0515
AstraZeneca Pharmaceuticals LP
2022/4/22 0:00:00
QUETIAPINE
DRUG FOR FURTHER PROCESSING
150
0310-0515_
quetiapine
DRUG FOR FURTHER PROCESSING
0310-0520
AstraZeneca Pharmaceuticals LP
2022/4/22 0:00:00
QUETIAPINE
DRUG FOR FURTHER PROCESSING
200
0310-0520_
quetiapine
DRUG FOR FURTHER PROCESSING
0310-0530
AstraZeneca Pharmaceuticals LP
2022/4/22 0:00:00
QUETIAPINE
DRUG FOR FURTHER PROCESSING
300
0310-0530_
quetiapine
DRUG FOR FURTHER PROCESSING
0310-0540
AstraZeneca Pharmaceuticals LP
2022/4/22 0:00:00
QUETIAPINE
DRUG FOR FURTHER PROCESSING
400
0310-0540_
Osimertinib
DRUG FOR FURTHER PROCESSING
0310-1353
AstraZeneca Pharmaceuticals LP
2021/6/1 0:00:00
OSIMERTINI
DRUG FOR FURTHER PROCESSING
40
0310-1353_
Osimertinib
DRUG FOR FURTHER PROCESSING
0310-1354
AstraZeneca Pharmaceuticals LP
2021/6/1 0:00:00
OSIMERTINI
DRUG FOR FURTHER PROCESSING
80
0310-1354_
Sodium Zirconium Cyclosilicate
BULK INGREDIENT
0310-2111
AstraZeneca Pharmaceuticals LP
2021/12/1 0:00:00
SODIUM ZIR
BULK INGREDIENT
243
0310-2111_
benralizumab
BULK INGREDIENT
0310-2830
AstraZeneca Pharmaceuticals LP
2022/2/4 0:00:00
BENRALIZUM
BULK INGREDIENT
46.7
0310-2830_
anifrolumab
BULK INGREDIENT
0310-3000
AstraZeneca Pharmaceuticals LP
2021/7/30 0:00:00
ANIFROLUMA
BULK INGREDIENT
11.7
0310-3000_
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3